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The transcriptional corepressor CtBP2 is essential for proper development of the nervous system.
The factor exerts its repression by interacting in complexes with chromatin-modifying factors
such as histone deacetylases (HDAC) 1/2 and the histone demethylase LSD1/KDM1. Notably, the
histone acetyl transferase p300 acetylates CtBP2 and this is an important regulatory event of the
activity and subcellular localization of the protein. We recently demonstrated an essential role for
CtBPs as sensors of microenvironmental oxygen levels inﬂuencing the differentiation potential of
neural stem cells (NSCs), but it is not known whether oxygen levels inﬂuence the acetylation
levels of CtBP factors. Here we show by using proximity ligation assay (PLA) that CtBP2 ace-
tylation levels increased signiﬁcantly in undifferentiated, proliferating NSCs under hypoxic
conditions. CtBP2 interacted with the class III HDAC Sirt1 but this interaction was unaltered in
hypoxic conditions, and treatment with the Sirt1 inhibitor Ex527 did not result in any signiﬁcant
change in total CtBP2 acetylation levels. Instead, we revealed a signiﬁcant decrease in PLA signal
representing CtBP2 dimerization in NSCs under hypoxic conditions, negatively correlating with
the acetylation levels. Our results suggest that microenvironmental oxygen levels inﬂuence the
dimerization and acetylation levels, and thereby the activity, of CtBP2 in proliferating NSCs.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
The development of the mammalian cortex is a complicated
process involving many cellular events, including proliferation,
differentiation, cell death, senescence, autophagy, migration, and
axon pathﬁnding, and these events are controlled by secreted
signaling factors, intrinsic signaling pathways, and ultimately
transcriptional regulators of gene expression [1–3]. In recent years,
the strong inﬂuence of the microenvironment on the state of
undifferentiated neural progenitors has been acknowledged [4].lsevier Inc. This is an open
3.0/).
ermanson).Hence, in addition to external signaling factors such as FGFs, BMPs,
neurotrophic factors, IL-6 related cytokines and hormones such as
retinoic acid and thyroid hormone to mention a few, the impor-
tance of extracellular matrix, stiffness, roughness, oxygen levels,
and the spatial variation in such inﬂuences creating gradients to be
interpreted by the progenitor cell have been highlighted [5–7].
Thus, to achieve a greater understanding of neural differentiation
and thereby provide the basis for development of new tools for
diagnosis, prognosis, and treatment of neurodevelopmental and
neurological disorders, a broad knowledge of the mechanismsaccess article under the CC BY-NC-ND license
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nucleus is required.
The transcriptional regulators CtBP1 and CtBP2 are particularly
interesting in this context. Identiﬁed in cancer research and later
shown to be essential for nervous system development, CtBP1/2Fig. 1 – CtBP2 and Sirt1 interaction in the nuclei of neural stem c
(NSCs) after proximity ligation assay (PLA) experiments demonstr
predominantly nuclear localization. (B) Colocalization of DAPI and
Z-stacks. (C) Micrographs depicting decreased CtBP2–Sirt1 PLA sig
CtBP2þSirt1 (F-actin green, DAPI blue). (D–F) Quantiﬁcations of Ct
following siRNA knockdown of CtBP2 and/or Sirt1. Data are presenhas been shown to be members of transcriptional corepressor
complexes together with class I histone deacetylases (HDACs)
HDAC1/2 and histone H3K4 demethylases such as LSD1/KDM1
[8–10]. CtBP1 has further been associated with CoREST and there
by REST, a major repressor of neuronal genes, and it has beenells. (A) Micrograph depicting proliferating neural stem cells
ating CtBP2 and Sirt1 are located in close proximity with
PLA signal from cross-sectional view in 3D rendering of
nal (red) following siRNA knockdown of CtBP2, Sirt1, and
BP2–Sirt1 PLA (D), CtBP2 single PLA (E), and Sirt1 single PLA (F)
ted as mean PLA signal per cell7S.E.M (n¼3). Scale bar¼10 lm.
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constituents to mediate coordinated deacetylation and methylation
of lysine 9 residues on histone H3 [11]. CtBP1/2 have also been
shown to play major roles in regulating differentiation potential,
epithelial-to-mesenchymal transition (EMT), and cell survival
[12,13]. The activities of CtBP1/2 have been shown to be regulated
by various mechanisms. CtBP1/2 are sensitive to NAD/NADH levels,
implying a regulation by metabolic state and oxygen levels, and we
recently showed that CtBPs function as sensors of microenviron-
mental oxygen levels in the presence of BMP, directly inﬂuencing
the differentiation potential of neural stem cells [14]. CtBP2 has
further been shown to be acetylated by the major histone acetyl
transferase (HAT) p300 [15,16], and this modiﬁcation strongly
inﬂuences the subcellular localization and thus the repression
exerted by the factor. Less is however known of a CtBP1/2 deace-
tylase or whether microenvironmental oxygen levels inﬂuence
acetylation levels and transcriptional activity of CtBP1/2.
Another transcriptional regulator that is inﬂuenced by the NAD/
NADH ratio is the class III histone deacetylase Sirt1. A number of
targets for p300 HAT activity have also been shown to be targets for
Sirt1 deacetylase activity, including the tumor suppressor p53 [17].
Notably, we and others have shown that Sirt1 can act as a repressor
of neuronal differentiation in neural stem cells [18–20], how-
ever see also [21], and it has been demonstrated that Sirt1 gene
expression can be regulated by CtBP1 [22], but it is not known
whether Sirt1 can interact directly with or deacetylate CtBP2.
To enable studies of protein interactions and modiﬁcations in
neural stem cells derived from the mammalian embryonic cortex
(NSCs), we employed proximity ligation assay (PLA) in this system
[23,24]. We aimed at investigating whether i) total acetylation
levels of CtBP2 were inﬂuenced by oxygen levels, ii) the NAD/
NADHþ-sensitive deacetylase Sirt1 could interact with CtBP2,
iii) CtBP2 is a target of Sirt1, and iv) the dimerization of CtBP2
could be affected by oxygen levels, and/or correlated with the total
acetylation levels of CtBP2. Using PLA, we have found that the total
acetylation levels of CtBP2 are altered under hypoxic conditions in
NSCs and that this modiﬁcation showed a negative correlationwith
dimerization. We further demonstrate that CtBP2 interact withFig. 2 – Increased CtBP2 total acetylation levels in NSCs after
metabolic changes. (A) NADH/NADþ assay demonstrating an
upregulation of NADH/NADþ ratio when NSCs are grown in 1%
oxygen, and a downregulation of the ratio after 2DG
treatment. Data are presented as mean7S.E.M. (n¼3; t¼7.05
(hypoxia), t¼1.84 (2DG)). (B) Micrographs depicting PLA signal
after using an antibody speciﬁc for acetylated lysines in
combination with CtBP2 antibody (CtBP2-Ac) following
normoxia, hypoxia, and 2DG treatments. (C) Quantiﬁcation of
CtBP2-Ac-dependent PLA signal showed increased acetylation
of CtBP2 under hypoxic conditions. Data are shown as mean
PLA signal count per cell7S.E.M. (n¼5; t¼2.98 (hypoxia),
t¼2.67 (2DG)). (D) Micrographs depicting PLA product after
detection of CtBP2-Sirt1 interaction under normoxia, hypoxia,
and 2DG treatments. (E) Quantiﬁcation of PLA signal after
investigating CtBP2–Sirt1 interaction revealed no signiﬁcant
changes after hypoxia or 2DG treatments compared to
normoxia (n¼5; t¼0.27 (hypoxia), t¼0.99 (2DG)). Differences
between means were analyzed using one-way ANOVA followed
by Bonferroni's test. All data are presented as mean7S.E.M.
(npo0.5, nnnpo0.001). Scale bar¼10 lm.Sirt1 in NSCs but no evidence was found to establish that CtBP2 is a
bonaﬁde Sirt1 target. We suggest that CtBP2 acetylation and
dimerization are altered by microenvironmental oxygen levels in
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events of neural differentiation and development.Materials and methods
Cell culture
The isolation and expansion of neural stem cells derived from
embryonic rat cortex was essentially performed as previously
described [25,26]. Cortical neural stem cells (NSC) were dissected
from E15.5 rat embryos and seeded in DMEM/F12 enriched with
N2 supplement on coated plates. NSCs were mechanically split
using HANKS and used for experiments at passage 1 and 2 (P1
and P2). Cells were fed FGF2 (10 ng/ml, RD, 233-FB) every day and
the media was changed every other day. For metabolic treatments
cells were grown in hypoxia chamber (1% oxygen) or treated with
5 mM 2DG (2-Deoxy-D-glucose) (Sigma, D6134) overnight. In
order to inhibit Sirt1 cells were treated with 1 mM Ex527 (Tocris,
2780) overnight or 5 mM Ex527 for 5 h. To study effects of H2O2
induced DNA damage on p53 and CtBP2 acetylation NSCs were
treated with 500 mM of H2O2 for 30 min and 1 h.Proximity ligation assay (PLA)
For detection of protein–protein interactions and total amount of
proteins Proximity Ligation Assay kit (DuoLink/Sigma; DUO92101)
was used. NSCs were grown on glass coverslips, ﬁxed in 4% PFA for
10min followed by 15min permeabilization in 0.1% Triton X-100. PLA
was carried out according to manufacturer's manual using kit
reagents. The probe and antibody concentrations were optimized
for each assay. F-actin counterstaining was carried out following the
last wash of PLA using Alexa488-Phalloidin (Molecular Probes). Cells
were mounted in DuoLink mounting medium and imaged with
ﬂuorescent microscopy. Images were sharpened using image decon-
volution software Autoquant and analyzed with ImageJ. The primary
antibodies used for PLA assays were targeted to overlapping regions
at the C-terminus of human CtBP2: CtBP2 mouse monoclonal anti-
body targeted to mouse CtBP2 amino acids 361–445 (BD Biosciences,
612044, 1:200), CtBP2 rabbit monoclonal antibody targeted to human
CtBP2 amino acids 415–445 (Epitomics/Abcam; ab128871, 1:200).
Sirt1 rabbit polyclonal antibody (Santa Cruz, sc-15404, 1:50), pan-
Acetylated lysine antibody (Cell Signaling, 9441, 1:200), p53 mouse
monoclonal (Cell Signaling, 2524, 1:200).Fig. 3 – No signiﬁcant effects of Sirt1 inhibition on total CtBP2
acetylation levels. (A) Quantiﬁcation of CtBP2-Ac-dependent
PLA product. (B) Quantiﬁcation of PLA product elicited by
CtBP2–Sirt1 antibodies following treatment with Sirt1
inhibitor Ex527 in combination with normoxia and hypoxia.
The effect of Ex527 treatment was analyzed using two-way
ANOVA followed by t-test for CtBP2-Acetyl PLA. The signal after
CtBP2–Sirt1 PLA was not signiﬁcantly inﬂuenced by metabolic
changes or Ex527 treatment according to two-way ANOVA test
(n¼3). (C) Quantiﬁcation of CtBP2-Ac-dependent PLA signal in
NSCs in response to siRNA knockdown of Sirt1 and CtBP2. All
data are presented as mean PLA count per cell7S.E.M. (n¼3;
npo0.05). Scale bar¼10 lm.siRNA knockdown
For siRNA-mediated knockdown of CtBP2 and Sirt1, Amaxa NSC
Nucleofection kit (Lonza) was used according to manufacturer's
E X P E R I M E N T A L C E L L R E S E A R C H 3 3 2 ( 2 0 1 5 ) 1 2 8 – 1 3 5132optimized protocol. Both CtBP2 and Sirt1 siRNA were obtained
from Dharmacon (Accell and ON-TARGETplus siRNA). Following
nucleofection, NSCs were seeded in 35 mm plates in N2 media
under proliferative conditions. The results were analyzed 48 h
later by RT-qPCR.
RT-qPCR
RNA was isolated from cells using Qiagen RNeasy mini kit. 400 ng
of RNA was used for RT-PCR carried out with Applied Biosystems
High Capacity cDNA Reverse Transcription kit. Q-PCR was per-
formed with Invitrogen's Platinum SYBR Green mix according to
manufacturer's manuals.
NADH/NADþ Assay
In order to detect free NADH and NADþ inside the cells under
normoxic and hypoxic conditions we used Abcam NAD/NADH assay
kit (ab65348). After rinsing with PBS, 2106 cells were pelleted
and the assay was carried out according to manufacturer's protocol.
Immunoblotting
For immunoblotting experiments, the Bio-Rad Mini-Protean 3
system was used. Electrophoresis and transfer steps were carried
out according to manufacturer's protocols. 30 mg protein was
loaded per lane. Following transfer to nitrocellulose membranes,
the blot was blocked and probed using Li–Cor reagents and
visualized with Odyssey infra-red system. The antibodies used for
western blot were: CtBP2 rabbit monoclonal (Abcam/Epitomics,
ab128871, 1:2000), Sirt1 rabbit polyclonal (Santa Cruz, sc-15404,
1:100) and Beta-actin mouse monoclonal (Sigma, A5441, 1:4000).Fig. 4 – Total amount of CtBP2 and Sirt1 comparing single PLA
with immunoblotting. Quantiﬁcations of the total amount of
CtBP2 (A) and Sirt1 (B) detected by single PLA under normoxia,
hypoxia, 2DG, and Ex527 treatments. The means of nuclear and
cytoplasmic PLA signals were compared separately using one-
way ANOVA followed by Bonferroni's test. No signiﬁcant
changes were detected. (C) Immunoblotting analysis of CtBP2
and Sirt1 levels in whole cell lysates of NSCs grown under the
same conditions as in A and B.Results and discussion
CtBP2 and SIRT1 are located in close proximity in
undifferentiated, proliferating neural stem cells
We speculated whether Sirt1 could directly interact with CtBPs, in
particular CtBP2 due to its veriﬁed role in the development of the
forebrain [27]. To test this hypothesis, we employed proximity
ligation assay (PLA). PLA enables the detection of interactions
between endogenous proteins within 40 nm distance to each
other [28]. In addition, as PLA results in a ﬂuorescent signal
detectable by conventional microscopy, it is further possible to
analyze the subcellular localization of the putative interaction.
This approach revealed that CtBP2 and Sirt1 are in close proximity
in NSCs (Fig. 1A). The signal was predominantly nuclear, and this
nuclear localization of the PLA signal was conﬁrmed in a cross-
sectional view of a 3D image (Fig. 1B). To control for the speciﬁcity
of the PLA signal, siRNA knockdown of CtBP2 and Sirt1 in parallel
experiments were performed. The amount of PLA signal per cell
was reduced 50–60% (in nuclei, control levels (mean7S.E.M.):
11.1370.51; after siRNA: 5.2471.01 (siCtBP2), 6.9571.26 (siSirt1),
4.6571.24 (siCtBP2þsiSirt1)) following siRNA knockdown with
nucleofection efﬁciency being typically around 50% (Figs. 1C–F).
These results indicate that CtBP2 and Sirt1 are located in close
proximity in the nuclei of proliferating NSCs, suggesting either a
direct interaction or co-localization to the same nuclear complex.Hypoxic conditions alter the acetylation levels of CtBP2 but
do not affect the close localization to Sirt1
As mentioned above, CtBP2 has been demonstrated to be acetylated
by the HAT p300 [15] and a number of proteins acetylated by p300
are in parallel substrates for the class III histone deacetylase Sirt1,
including the tumor suppressor protein p53 [17]. Since we rece-
ntly reported that the activity of CtBP proteins are inﬂuenced by
microenvironmental oxygen levels, and since CtBP2 was found in
close proximity to Sirt1, we asked whether CtBP2 acetylation could
be inﬂuenced by changes in oxygen levels and further whether the
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conditions.
As both Sirt1 and CtBP2 are inﬂuenced by NADH/NADþ levels,
we ﬁrst investigated the effect of metabolic changes on the total
acetylation levels of CtBP2. NADH/NADþ ratio was increased
approximately 3-fold when cells were incubated in 1% oxygen
(0.1170.0073 (control) versus 0.3070.039 (hypoxic)), and red-
uced E40% upon treatment of NSCs with 2-Deoxy-D-glucose
(2DG; 0.06670.016), which acts as a glycolytic inhibitor (Fig. 2A).
Previously, hypoxic conditions have been shown to inhibit Sirt1
whereas treatment with 2DG increases the activity, directly or
indirectly [22]. Upon hypoxia treatment or treatment with 2DG,
the total acetylation levels of nuclear CtBP2 was increased
approximately 50% as assessed by PLA signal count per cell
(16.96 versus 25.83 and 24.89, respectively) in NSCs as detected
by PLA (Figs. 2B and C). However, analyses of the putative CtBP2–
Sirt1 interaction in response to the metabolic stimuli demon-
strated that the PLA signal did not change signiﬁcantly with
hypoxia or 2DG treatments (Figs. 2D and E). These results indicate
that total CtBP2 acetylation levels are altered under hypoxic
conditions and after 2DG treatment in NSCs, but that these
conditions do not affect the close proximity between CtBP2
and Sirt1.The oxygen-dependent alteration in total CtBP2
acetylation levels seems to be independent of Sirt1 activity
Although the close proximity of CtBP2 and Sirt1 in NSCs was
unaltered under hypoxic conditions, this experiment did not rule
out the possibility that CtBP2 could be targeted by Sirt1 deace-
tylase activity. Therefore, we treated the NSCs with the speciﬁc
Sirt1 inhibitor Ex527 to investigate whether Sirt1 could be a
regulator of total CtBP2 acetylation under hypoxic conditions.
However, Ex527 did not show any signiﬁcant effect on the total
acetylation levels of CtBP2 nor in the proximity of CtBP2 and Sirt1,
either in combination with normoxia or hypoxia (Figs. 3A and B).
Accordingly, whereas CtBP2 siRNA treatment expectedly caused a
3-fold drop in CtBP2 acetylation as assessed by the PLA signalFig. 5 – DNA damage induced p53 acetylation can be conﬁrmed
by PLA. (A) Images of p53-Acetylated lysine (p53-Ac) PLA
following exposure to hydrogen peroxide for 30 min or 1 h. (B)
Quantiﬁcation of p53-Ac PLA shows signiﬁcant increase of p53
acetylation upon 1 h H2O2 treatment. According to two-way
ANOVA Sirt1 inhibitor Ex527 did not have a signiﬁcant effect.
H2O2 induced p53 acetylation was analyzed using one-way
ANOVA followed by Bonferroni's test. (n¼5, t¼1.6 (H2O2
30 min), t¼3.9 (H2O2 1 h)). (C) Images of CtBP2-Ac-elicited PLA
signal under treatment of H2O2 for 30 min or 1 h.
(D) Quantiﬁcation of CtBP2-Ac PLA shows signiﬁcant decrease
of CtBP2 total acetylation levels upon H2O2 treatment.
According to two-way ANOVA Ex527 did not have a signiﬁcant
effect. Effect of H2O2 was analyzed with one-way ANOVA
followed by Bonferroni's test. (n¼3, t¼7.1 (H2O2 30 min), t¼7.7
(H2O2 1 h)) E) CtBP2 single PLA to compare total levels of CtBP2
upon H2O2 treatment. 2-way ANOVA showed no signiﬁcant
effect of Ex527 or H2O2 treatments on CtBP2 levels. (Scale
bar¼10 lM.) (npo0.05, nnpo0.01). All data are presented as
meanþs.e.m.(Fig. 3C), Sirt1 siRNA resulted in a small decrease in CtBP2
acetylation that failed to reach statistical signiﬁcance (Fig. 3C).
To exclude whether changes in protein levels were inﬂuencing
the results, we compared the total amount of CtBP2 and Sirt1
Fig. 6 – Alteration of CtBP2 homodimerization in proliferating NSCs in response to metabolic changes. (A) Micrograph depicting
the PLA product in NSCs demonstrating CtBP2 homodimers following normoxia, hypoxia, and 2DG treatments. (B) Quantiﬁcation
of the PLA signal representing CtBP2 homodimers unveiled a signiﬁcant decrease upon hypoxic treatment. Means were compared
using one-way ANOVA followed by Bonferroni's test. Data are presented as mean PLA signal count per cell7S.E.M. (n¼4; t¼4.5
(hypoxia), t¼2.3 (2-DG)). (C) Quantiﬁcation of the PLA product representing CtBP2 homodimers after CtBP2 RNA knockdown as a
control for the speciﬁcity of the PLA signal. Sirt1 siRNA knockdown had no signiﬁcant effect on CtBP2 homodimerization. Error
bars are S.E.M., n¼3; nnpo0.01. Scale bar¼10 lm).
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This was pursued by using one primary antibody and complemen-
tary probes targeted against the species of the primary antibody to
provide a quantitative measure of protein amount and location.
These experiments conﬁrmed that there were no signiﬁcant
differences in CtBP2 and Sirt1 single PLA levels under normoxia,
hypoxia, or 2DG or Ex527 treatments (Figs. 4A and B). Sirt1 showed
a slight variation in cytoplasmic location but this observation did
not reach statistical signiﬁcance (Fig. 4B). These results using the
PLA approach were conﬁrmed using immunoblotting (Fig. 4C).
The tumor suppressor p53 is a well-established target of Sirt1
[17]. To verify the negative results regarding the hypothetical
regulation of CtBP2 by Sirt1, as well as the altered acetylation
levels of CtBP2 under hypoxic conditions using PLA, we tested
whether we could detect the established increase in acetylation of
p53 by the PLA method by using DNA damaging agents. Treatment
of NSCs with H2O2 resulted in a signiﬁcant increase in acetylation
of p53 in NSCs (Figs. 5A and B). Interestingly, total acetylation levels
of CtBP2 in NSCs were signiﬁcantly decreased by treatment with
H2O2 as assessed by quantiﬁcation of PLA signal per cell (17.39
versus 10.34 (30 min) and 9.66 (1 h)) but not by Ex527 (Figs. 5Cand D) while the levels of total CtBP2 were unaltered by the same
treatment (Fig. 5E). In summary, these observations suggest that
CtBP2 is not a target of Sirt1 but rather that the two proteins are
interacting in a cell context-dependent manner in NSCs.
Alteration of dimerization in hypoxic conditions correlates
negatively with the total acetylation levels of CtBP2
Next, we asked whether hypoxic conditions could inﬂuence the
dimerization of CtBP2. We therefore performed PLA using two
primary antibodies that were targeted to overlapping regions at the
C-terminus of CtBP2. Importantly, under hypoxic conditions, the
PLA signal for CtBP2 homodimer showed a small but reproducible
decrease (19.83 versus 15.2; po0.01; Figs. 6A and B). In accordance
with previous experiments, CtBP2 siRNA caused a E75% decrease
in CtBP2 homodimer PLA signal whereas siRNA against Sirt1 was
not effective (Fig. 6C).
Although we here show that PLA is a useful tool for analyzing
protein interactions, enzymatic modiﬁcations, and homodimeriza-
tions in NSCs, there are some caveats to be discussed. For example, it
should be noted that this approach with PLA cannot distinguish
E X P E R I M E N T A L C E L L R E S E A R C H 3 3 2 ( 2 0 1 5 ) 1 2 8 – 1 3 5 135dimers from higher order oligomerization such as tetramers, which
CtBP proteins are suggested to form based on its crystal structure
[29]. Further, it should be emphasized that our analysis of CtBP2
acetylation was aimed at elucidating total acetylation levels. Changes
in single lysine residues may therefore escape our detection, which is
important to keep in mind when interpreting the negative results
regarding the role for Sirt1.
We conclude that microenvironmental oxygen levels inﬂuence
the total acetylation levels and homodimerization of CtBP2. We
further show that CtBP2 are in close proximity to, and thus lik-
ely interact in a complex with, the deacetylase Sirt1, but this
interaction does not seem to play a critical role for the alteration
in total acetylation of CtBP2 under hypoxic conditions.Acknowledgments
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